BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

437 related articles for article (PubMed ID: 11139877)

  • 1. [Post-parotidectomy Frey's syndrome. Treatment with botulinum toxin type A].
    Cavalot AL; Palonta F; Preti G; Nazionale G; Ricci E; Staffieri A; Di Girolamo S; Cortesina G
    Acta Otorhinolaryngol Ital; 2000 Jun; 20(3):187-91. PubMed ID: 11139877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Severe Frey syndrome after parotidectomy: treatment with botulinum neurotoxin type A].
    Laccourreye O; Muscatello L; Gutierrez-Fonseca R; Seckin S; Brasnu D; Bonan B
    Ann Otolaryngol Chir Cervicofac; 1999 Jun; 116(3):137-42. PubMed ID: 10399528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of Frey's syndrome with botulinum toxin.
    Pomprasit M; Chintrakarn C
    J Med Assoc Thai; 2007 Nov; 90(11):2397-402. PubMed ID: 18181326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of gustatory sweating (Frey's syndrome) with botulinum toxin A.
    Eckardt A; Kuettner C
    Head Neck; 2003 Aug; 25(8):624-8. PubMed ID: 12884344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Botulinum toxin A for quality of life improvement in post-parotidectomy gustatory sweating (Frey's syndrome).
    Hartl DM; Julieron M; LeRidant AM; Janot F; Marandas P; Travagli JP
    J Laryngol Otol; 2008 Oct; 122(10):1100-4. PubMed ID: 18289458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of Frey's syndrome with botulinum A toxin].
    Braunius WW; Gerrits MA
    Ned Tijdschr Geneeskd; 1998 Apr; 142(15):859-63. PubMed ID: 9623161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of botulinum toxin in Frey's Syndrome.
    Khoo SG; Keogh IJ; Timon C
    Ir Med J; 2006 May; 99(5):136-7. PubMed ID: 16892916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical results in the management of Frey's syndrome with injections of Botulinum toxin.
    Martos Díaz P; Bances del Castillo R; Mancha de la Plata M; Naval Gías L; Martínez Nieto C; Lee GY; Muñoz Guerra M
    Med Oral Patol Oral Cir Bucal; 2008 Apr; 13(4):E248-52. PubMed ID: 18379450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Botulinum toxoid in the management of gustatory sweating (Frey's syndrome) after superficial parotidectomy.
    Birch JF; Varma SK; Narula AA
    Br J Plast Surg; 1999 Apr; 52(3):230-1. PubMed ID: 10474477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased botulinum toxin type A dosage is more effective in patients with Frey's syndrome.
    Guntinas-Lichius O
    Laryngoscope; 2002 Apr; 112(4):746-9. PubMed ID: 12150533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of Frey's syndrome with botulinum toxin type B.
    Cantarella G; Berlusconi A; Mele V; Cogiamanian F; Barbieri S
    Otolaryngol Head Neck Surg; 2010 Aug; 143(2):214-8. PubMed ID: 20647122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of facial palsy and severe Frey's syndrome after conservative parotidectomy for benign disease: analysis of 610 operations.
    Guntinas-Lichius O; Gabriel B; Klussmann JP
    Acta Otolaryngol; 2006 Oct; 126(10):1104-9. PubMed ID: 16923718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Control of Frey's syndrome in patients treated with botulinum toxin type A.
    Luna Ortiz K; Rascon Ortiz M; Sansón Riofrio JA; Villavicencio Valencia V; Mosqueda Taylor A
    Med Oral Patol Oral Cir Bucal; 2007 Jan; 12(1):E79-84. PubMed ID: 17195837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of gustatory sweating with low-dose botulinum toxin A: a case report.
    Bakke M; Max Thorsen N; Bardow A; Dalager T; Eckhart Thomsen C; Regeur L
    Acta Odontol Scand; 2006 Jun; 64(3):129-33. PubMed ID: 16809188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Botulinum toxin type A for Frey's syndrome: a preliminary prospective study.
    Laccourreye O; Muscatelo L; Naude C; Bonan B; Brasnu D
    Ann Otol Rhinol Laryngol; 1998 Jan; 107(1):52-5. PubMed ID: 9439389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of Frey's syndrome using botulinum toxin].
    Bachmann-Harildstad G; Wenus S; Vik O
    Tidsskr Nor Laegeforen; 2005 Oct; 125(19):2624-6. PubMed ID: 16215605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Diagnostic image (147) A man with gustatory sweating. Frey's syndrome].
    van den Hoogen FJ; Marres HA
    Ned Tijdschr Geneeskd; 2003 Jul; 147(28):1356. PubMed ID: 12892011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The incidence of Frey's syndrome.
    Rustemeyer J; Eufinger H; Bremerich A
    J Craniomaxillofac Surg; 2008 Jan; 36(1):34-7. PubMed ID: 18023355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of acellular dermis in the prevention of Frey's syndrome.
    Govindaraj S; Cohen M; Genden EM; Costantino PD; Urken ML
    Laryngoscope; 2001 Nov; 111(11 Pt 1):1993-8. PubMed ID: 11801985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of Frey syndrome.
    de Bree R; van der Waal I; Leemans CR
    Head Neck; 2007 Aug; 29(8):773-8. PubMed ID: 17230557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.